Evidence map›Paper›PMID 41335283›Full record

ReviewBioresources and bioprocessing2025

Valorisation of fish scales and bones: a sustainable source of bioactive proteins and collagen for nutraceuticals.

Sivakamavalli Jeyachandran, Mohammed Aman

Abstract readReview
In one paragraph

Review in Bioresources and bioprocessing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Simulated Gastrointestinal Digestion of Tilapia (Foods (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sivakamavalli JeyachandranLab in Biotechnology and Biosignal Transduction, Department of Orthodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, 600077, India. sivakamavalli.sdc@saveetha.com.
Mohammed AmanDepartment of Industrial Engineering, College of Engineering, University of Business and Technology, 21448, Jeddah, Saudi Arabia.

Funding

DST-SERB SPG/2021/003904
6 · The paper itself

Abstract

Fish scales and bones, traditionally regarded as low-value seafood by-products, represent abundant and sustainable sources of collagen and bioactive proteins with high nutraceutical potential. These tissues typically contain 30-40% organic collagen matrix and 60-70% hydroxyapatite minerals, making them rich substrates for recovery. Advances in green and enzymatic extraction methods now achieve collagen yields of up to 25-35%, with ultrasound- and microwave-assisted extraction reducing processing times from days to minutes while preserving the triple-helix structure and bioactivity. Enzymatically derived peptides demonstrate potent health-promoting effects, with antioxidant capacities comparable to or exceeding vitamins C and E, ACE-inhibitory peptides lowering blood pressure in preclinical models, and clinical trials showing that daily supplementation with 10 g fish collagen peptides for 8-12 weeks improves skin hydration, elasticity, wrinkle reduction, and reduces osteoarthritis-related joint pain. These marine biomolecules, when delivered through advanced nanocarrier systems such as nanoliposomes and nanoemulsions, exhibit enhanced bioavailability, stability, and consumer acceptability. Beyond health benefits, valorisation of fish by-products supports environmental sustainability by diverting waste and contributing to the circular bioeconomy. Despite challenges in scalability, regulatory compliance, and standardization, ongoing technological innovations position fish scales and bones as promising raw materials for next-generation nutraceuticals.

Indexed as

Bioactive marine peptidesEnzymatic hydrolysis techniquesSeafood waste valorisationSustainable collagen sources

Identifiers

PMID41335283
PMCPMC12675900

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.